TickerGuard
Buy Day today: Poor (42) Weak market breadth · today: Nonfarm Payrolls (October)
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

44.50$ -6.1% vs. previous close Closing price · As of: Nov 5, 2026

Ownership

Ownership Structure

Who owns Liquidia Technologies Inc (LQDA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.9% of the shares are freely tradable; institutional investors hold 70.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 70.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 12.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 17.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 90Mio.

Largest Shareholders

Institutions

Institutions LQDA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 12.05 10,788,586 +96.5 06/30/2026
Farallon Capital Management, L.L.C. 9.35 8,365,038 -3.4 06/30/2026
Caligan Partners LP 9.07 8,118,892 +0.0 06/30/2026
Findell Capital Management LLC 3.91 3,502,112 +0.0 06/30/2026
Vanguard Capital Management, LLC 3.51 3,139,183 +7.3 06/30/2026
State Street Corp 3.39 3,030,395 +61.1 06/30/2026
Opaleye Management Inc 2.73 2,447,500 -3.8 06/30/2026
Geode Capital Management, LLC 2.37 2,121,290 +10.0 06/30/2026

Funds

Funds LQDA
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 4.94 4,424,930 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.54 2,270,164 +0.3 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings LQDA
Person Role Shares Value As of Type
Jeffs Roger Chief Executive Officer 1,125,848 50,100,236 $ Oct 12, 2026 direct
Schundler Russell General Counsel 602,841 26,826,425 $ Oct 12, 2026 direct
Kaseta Michael CFO and COO 340,148 15,136,586 $ Oct 12, 2026 direct
Moomaw Scott Chief Commercial Officer 181,487 8,076,172 $ Oct 12, 2026 direct
Adair Jason Chief Business Officer 177,269 7,888,471 $ Oct 26, 2026 direct
Boyle Dana Chief Accounting Officer 164,028 7,299,246 $ Oct 26, 2026 direct
Saggar Rajeev Chief Medical Officer 126,368 5,623,376 $ Oct 12, 2026 direct
Krepp Sarah Chief Human Resource Officer 115,241 5,128,225 $ Oct 12, 2026 direct
Khindri Sanjeev Chief Development Officer 64,846 2,885,647 $ Oct 12, 2026 direct
Singh Raman Director 44,637 1,986,347 $ Sep 14, 2026 direct
Rielly-Gauvin Katherine Director 44,637 1,986,347 $ Aug 20, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 26, 2026 Boyle Dana Chief Accounting Officer Sell 1,581 43.19 68,283
Oct 26, 2026 Adair Jason Chief Business Officer Sell 688 43.19 29,715
Oct 12, 2026 Schundler Russell General Counsel Sell 13,692 28.48 389,948
Oct 12, 2026 Saggar Rajeev Chief Medical Officer Sell 9,218 28.48 262,529
Oct 12, 2026 Moomaw Scott Chief Commercial Officer Sell 8,863 28.48 252,418
Oct 12, 2026 Krepp Sarah Chief Human Resource Officer Sell 5,245 28.48 149,378
Oct 12, 2026 Khindri Sanjeev Chief Development Officer Sell 1,101 28.48 31,356
Oct 12, 2026 Kaseta Michael CFO and COO Sell 18,938 28.48 539,354
Oct 12, 2026 Jeffs Roger Chief Executive Officer Sell 32,744 28.48 932,549
Oct 12, 2026 Boyle Dana Chief Accounting Officer Sell 5,892 28.48 167,804
Oct 12, 2026 Adair Jason Chief Business Officer Sell 7,301 28.48 207,932
Oct 9, 2026 Schundler Russell General Counsel Other 6,409 – –
Oct 9, 2026 Schundler Russell General Counsel Other 3,758 – –
Oct 9, 2026 Saggar Rajeev Chief Medical Officer Other 4,486 – –
Oct 9, 2026 Saggar Rajeev Chief Medical Officer Other 3,530 – –
Oct 9, 2026 Moomaw Scott Chief Commercial Officer Other 4,358 – –
Oct 9, 2026 Moomaw Scott Chief Commercial Officer Other 3,108 – –
Oct 9, 2026 Krepp Sarah Chief Human Resource Officer Other 3,178 – –
Oct 9, 2026 Kaseta Michael CFO and COO Other 7,049 – –
Oct 9, 2026 Kaseta Michael CFO and COO Other 5,828 – –
Oct 9, 2026 Jeffs Roger Chief Executive Officer Other 14,333 – –
Oct 9, 2026 Jeffs Roger Chief Executive Officer Other 13,833 – –
Oct 9, 2026 Boyle Dana Chief Accounting Officer Other 3,178 – –
Oct 9, 2026 Adair Jason Chief Business Officer Other 3,868 – –
Oct 9, 2026 Adair Jason Chief Business Officer Other 2,474 – –
Oct 9, 2026 Adair Jason Chief Business Officer Other 3,906 – –
Oct 5, 2026 Bloch Stephen M Director Sell 235,477 27.13 6,387,596
Sep 14, 2026 Singh Raman Director Sell 8,468 66.16 560,243
Sep 14, 2026 Singh Raman Director Other 8,468 9.31 78,799
Sep 11, 2026 Singh Raman Director Sell 9,024 68.62 619,210
Sep 11, 2026 Singh Raman Director Other 8,468 9.31 78,799
Sep 11, 2026 Singh Raman Director Other 556 8.63 4,798
Sep 1, 2026 Krepp Sarah Chief Human Resource Officer Sell 274 67.76 18,566
Aug 21, 2026 Adair Jason Chief Business Officer Sell 41,832 69.09 2,890,206
Aug 21, 2026 Adair Jason Chief Business Officer Sell 31,799 69.09 2,197,018
Aug 21, 2026 Adair Jason Chief Business Officer Other 238 14.20 3,380
Aug 21, 2026 Adair Jason Chief Business Officer Other 10,762 14.20 152,820
Aug 21, 2026 Adair Jason Chief Business Officer Other 11,799 9.31 109,849
Aug 21, 2026 Adair Jason Chief Business Officer Other 9,000 9.31 83,790
Aug 20, 2026 Rielly-Gauvin Katherine Director Sell 18,393 72.23 1,328,477
Aug 20, 2026 Rielly-Gauvin Katherine Director Other 6,666 2.59 17,265
Aug 20, 2026 Rielly-Gauvin Katherine Director Other 11,727 2.51 29,435
Aug 19, 2026 Rielly-Gauvin Katherine Director Sell 36,789 74.99 2,758,958
Aug 19, 2026 Rielly-Gauvin Katherine Director Other 13,334 2.59 34,535
Aug 19, 2026 Rielly-Gauvin Katherine Director Other 23,455 2.51 58,872
Aug 19, 2026 Saggar Rajeev Chief Medical Officer Sell 50,000 74.06 3,702,825
Aug 19, 2026 Saggar Rajeev Chief Medical Officer Other 50,000 3.73 186,500
Aug 17, 2026 Saggar Rajeev Chief Medical Officer Sell 29,534 76.84 2,269,381
Jul 27, 2026 Boyle Dana Chief Accounting Officer Sell 1,600 87.53 140,048
Jul 27, 2026 Adair Jason Chief Business Officer Sell 688 87.53 60,221

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?